Bnp Paribas Viatris Inc Transaction History
Bnp Paribas
- $1.99 Trillion
- Q2 2024
A detailed history of Bnp Paribas transactions in Viatris Inc stock. As of the latest transaction made, Bnp Paribas holds 1,956 shares of VTRS stock, worth $22,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,956
Previous 460
325.22%
Holding current value
$22,044
Previous $5.49 Million
278.41%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VTRS
# of Institutions
1,099Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.58 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.04 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$700 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$648 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$640 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.7B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...